We are pleased to announce the partnership between BaseLaunch and Schrödinger!
A pioneer in pharmaceutical software, Schrödinger was founded in 1990. The company’s mission to improve healthcare has led to collaborations with pharma giants, such as Bayer and Bristol Myers Squibb.
Today, with over 650 employees and engagements with customers and collaborators in more than 70 countries, the New York-based company is a scientific leader in developing innovative software for improved drug discovery and materials design.
Its physics-based computational platform outdoes traditional methods thanks to lower costs and increased speed. Because of its unique efficiency, the Schrödinger software is deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories from all over the world.
Furthermore, Schrödinger’s multidisciplinary drug discovery team also leverages its innovative software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs.
Visit their website over here:
We look forward to working together!